MARADMINS : 673/13
R 191623Z DEC 13
UNCLASSIFIED/
MARADMIN 673/13
MSGID/GENADMIN,USMTF,2007/CMC WASHINGTON DC MRA(UC)/F002//
SUBJ/INCLUSION OF RANDOM SYNTHETIC CANNABINOIDS TO THE DRUG DEMAND/REDUCTION PROGRAM DRUG TESTING PANEL//
REF/A/MSGID:DOC/OUSD/YMD:20131025//
REF/B/MSGID:DOC/OUSD/YMD:20131101//
REF/C/MSGID:DOC/CMC WASHINGTON DC MRC4/YMD:20110411//
NARR/REF A IS UNDER SECRETARY OF DEFENSE MEMORANDUM, UPDATE TO THE DEPARTMENT OF DEFENSE DRUG TESTING PANEL. REF B IS OFFICE OF THE UNDER SECRETARY OF DEFENSE MEMORANDUM, PROGRAM GUIDANCE INCLUSION OF RANDOM SYNTHETIC CANNABINOIDS TO THE DRUG DEMAND REDUCTION PROGRAM DRUG PANEL. REF C IS MCO 5300.17 MARINE CORPS SUBSTANCE ABUSE PROGRAM.//
POC/ERIC C. HOLLINS/CIV/UNIT:MFCP/-/TEL:(703) 784-9526//
GENTEXT/REMARKS/1. THE PURPOSE OF THIS MARADMIN IS TO ANNOUNCE THE ADDITION OF SYNTHETIC CANNABINOIDS (SC) TESTING TO THE DRUG DEMAND REDUCTION PROGRAM TESTING PANEL NO LATER THAN 23 JAN 2014.
2. PER REFERENCES (A) AND (B), THE DEPARTMENT OF DEFENSE (DOD) WILL EXPAND ITS DRUG TESTING PANEL TO INCLUDE SC BECAUSE THE CAPABILITY NOW EXISTS TO TEST FOR THE MOST FREQUENTLY USED SC, SPICE, ON A LARGE SCALE. DRUG TESTING LABS WILL NOW TEST A PERCENTAGE OF URINALYSIS SAMPLES, SUBMITTED FOR SCREENING UNDER REF (C) USING THE RANDOM TESTING (IR) PREMISE CODE, FOR SC.
3. ALL URINALYSIS SAMPLES SUBMITTED PURSUANT TO AN INVESTIGATION OR URINALYSIS SAMPLES SUBMITTED PURSUANT TO COMMANDS ESTABLISHING GROUNDS FOR PROBABLE CAUSE WILL INCLUDE SC IN THE TESTING PANEL.
4. THE CHANGES IN DOD POLICY ANNOUNCED BY REFERENCES (A) AND (B) DO NOT AFFECT CURRENT MARINE CORPS PROCEDURES FOR SUBMITTING URINALYSIS SAMPLES. URINALYSIS SAMPLES WILL CONTINUE TO BE SUBMITTED IN ACCORDANCE WITH ESTABLISHED PROCEDURES.
5. REFERENCE (C) POLICY WILL BE UPDATED TO REFLECT THE CHANGES IDENTIFIED IN REFERENCES (A) AND (B).
6. THIS MARADMIN IS APPLICABLE TO THE MARINE CORPS TOTAL FORCE.
7. RELEASE AUTHORIZED BY BGEN R. A. C. SANBORN, DIRECTOR, MARINE AND FAMILY PROGRAMS DIVISION.